CompoAtlas

Alvityl® Vitalité 50+

Food supplement declared in France, declaration No 2022-2-1086, decision dated 22 February 2022

Alvityl® Vitalité 50+ is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
LABORATOIRES URGO HEALTHCARE
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Comprimé
Daily dose
1 comprimé effervescent par jour
Directions for use
1 comprimé effervescent par jour à dissoudre dans un grand verre d'eau (250 ml)
Intended populations
Personnes de plus de 60 ans, Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Hypertension
Objectives stated by the manufacturer (these are not authorised claims)
Os, Œil / Vision, Immunité
Flavourings
Tropical

Declaration 231604, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Eleutherococcus senticosus (Rupr. et Maxim.) MaximRacineExtrait sec hydroalcoolique180 mg
Vaccinium myrtillus L.FruitExtrait sec aqueux10 mg

Other active ingredients

NamePer day
Lutéinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
D-biotineBiotine (vitamine B8)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Sels calciques de l'acide orthophosphoriqueCalcium2,500 mg800 mg
Sulfate de cuivreCuivre5,000 µg2,000 µg
Sel de sodium de l'édétate de fer (III)Fer40 mg (niveau de sécurité)14 mg
L-méthylfolate de calciumFolates (vitamine B9)1,000 µg200 µg
Carbonate de magnésiumMagnésium250 mg300 mg
Sulfate de manganèseManganèse8 mg (niveau de sécurité)3.5 mg
Molybdate de sodiumMolybdène600 µg150 µg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Sélénite de sodiumSélénium255 µg50 µg
Acétate de rétinyleVitamine A3,000 µg d'équivalent rétinol800 µg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011
Riboflavine 5'-phosphateVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
L-ascorbate de sodiumVitamine Cpas de limite (données insuffisantes)180 mg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg
Oxyde de zincZinc25 mg15 mg

Additives

E420, E950, E955, E330, E1521, E500

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Une consommation excessive peut avoir des effets laxatifs. Contre-indiqué dans le cas d'hypertension. L'usage prolongé de plus de 3 mois est déconseillé. Ne doit pas être utilisé par les femmes enceintes ou allaitantes.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Eleutherococcus senticosus (Rupr. et Maxim.) Maxim
    Read the warning, when it applies and the studies cited

    ELEUTHERO - ELEUTHEROCOCCUS SENTICOSUS

    Route of administration: Oral (ESCOP 2003; Bradley 1992)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Barnes et al. 2007; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an acute infection (Brinker 2010; Mills and Bone 2000).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you have high blood pressure (Gardner and McGuffin 2013; Brinker 2010; Barnes et al. 2007; Blumenthal et al. 2000; Mills and Bone 2000).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 31 October 2025

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line